Table 7.
Chitosan Complex | Causative Agent | Immune Animal or Model | Immunization Mode |
---|---|---|---|
Chitosan–saponin [196] | Avian infectious bronchitis virus | Chicken | Intramuscular injection |
Chitosan–trimeric phosphate [194] | pVAX-OMP and pVAX-hly | Carp | Oral |
Polylactic-co-glycolic acid-chitosan NPs [197] | Late-onset Edwardian spp. | Fish | Immunization by immersion |
N-2-Hydroxypropyl dimethylethyl ammonium chloride chitosan NPs [38] | Newcastle disease virus | Chicken | Intranasal |
Mannosylated chitosan [198] | Mycobacterium pneumonia | Mouse | Intranasal |
N-2-HACC/CMCS NPs [40] | Newcastle disease virus | Chicken | Intranasal |
Chitosan NPs [199] | Herpes simplex virus | Duck | Intramuscular injection |
Chitosan NPs [200] | Hepatitis B antigen | Mouse | Intranasal |
Chitosan NPs [201] | Helicobacter pylori | Mouse | Oral |
Mannosylated chitosan NPs [202] | Mouth disease virus | Guinea pig | Intranasal |